Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The basic principle of chimeric antigen receptor T cell immunotherapy is to use the patient’s own immune cells to eliminate cancer cells. Among them, chimeric antigen receptor (CAR) is the core component of CAR-T, giving T cells HLA-independent recognition The ability of tumor antigens, which enables CAR-modified T cells to recognize a wider range of targets than the natural T cell surface receptor TCR. The basic design of CAR includes a tumor-associated antigen (TAA) binding region (usually derived from the scFV segment of the monoclonal antibody antigen binding region), an extracellular hinge region, a transmembrane region and an intracellular signal Area
LPI (LP Information)' newest research report, the “Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Forecast” looks at past sales and reviews total world Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy sales for 2023 through 2029. With Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy industry.
This Insight Report provides a comprehensive analysis of the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy.
The global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy players cover Pfizer, Novartis, Bristol Myers Squibb, Legend Biotech, Sorrento Therapeutics, CARSGEN Therapeutics?Ltd, Juno Therapeutics, Kite Pharma and Atara Biotherapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The basic principle of chimeric antigen receptor T cell immunotherapy is to use the patient’s own immune cells to eliminate cancer cells. Among them, chimeric antigen receptor (CAR) is the core component of CAR-T, giving T cells HLA-independent recognition The ability of tumor antigens, which enables CAR-modified T cells to recognize a wider range of targets than the natural T cell surface receptor TCR. The basic design of CAR includes a tumor-associated antigen (TAA) binding region (usually derived from the scFV segment of the monoclonal antibody antigen binding region), an extracellular hinge region, a transmembrane region and an intracellular signal Area
LPI (LP Information)' newest research report, the “Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Forecast” looks at past sales and reviews total world Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy sales for 2023 through 2029. With Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy industry.
This Insight Report provides a comprehensive analysis of the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy.
The global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy players cover Pfizer, Novartis, Bristol Myers Squibb, Legend Biotech, Sorrento Therapeutics, CARSGEN Therapeutics?Ltd, Juno Therapeutics, Kite Pharma and Atara Biotherapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Allogeneic CAR T-Cells
- Autologous CAR T-Cells
- Hospital
- Diagnostic Center
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Novartis
- Bristol Myers Squibb
- Legend Biotech
- Sorrento Therapeutics
- CARSGEN Therapeutics?Ltd
- Juno Therapeutics
- Kite Pharma
- Atara Biotherapeutics
- Carina Biotech
- Guangzhou Xiangxue Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2018-2029
2.1.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Segment by Type
2.2.1 Allogeneic CAR T-Cells
2.2.2 Autologous CAR T-Cells
2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
2.3.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
2.4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic Center
2.4.3 Others
2.5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
2.5.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
3 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Players
3.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Players (2018-2023)
3.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Players (2018-2023)
3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY BY REGIONS
4.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Regions (2018-2023)
4.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth (2018-2023)
4.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth (2018-2023)
4.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2018-2023)
5.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023)
5.3 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2018-2023)
6.2 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023)
6.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Country (2018-2023)
7.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023)
7.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Region (2018-2023)
8.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY MARKET FORECAST
10.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Regions (2024-2029)
10.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Regions (2024-2029)
10.1.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast
10.1.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast
10.1.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast
10.1.5 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast
10.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Country (2024-2029)
10.2.1 United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.2.2 Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.2.3 Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.2.4 Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Region (2024-2029)
10.3.1 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.2 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.3 Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.4 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.5 India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.6 Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Country (2024-2029)
10.4.1 Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4.2 France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4.3 UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4.4 Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4.5 Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Region (2024-2029)
10.5.1 Egypt Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5.2 South Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5.3 Israel Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5.4 Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5.5 GCC Countries Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.6 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Type (2024-2029)
10.7 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.1.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.2.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Information
11.3.2 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.3.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Bristol Myers Squibb Main Business Overview
11.3.5 Bristol Myers Squibb Latest Developments
11.4 Legend Biotech
11.4.1 Legend Biotech Company Information
11.4.2 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.4.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Legend Biotech Main Business Overview
11.4.5 Legend Biotech Latest Developments
11.5 Sorrento Therapeutics
11.5.1 Sorrento Therapeutics Company Information
11.5.2 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.5.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sorrento Therapeutics Main Business Overview
11.5.5 Sorrento Therapeutics Latest Developments
11.6 CARSGEN Therapeutics?Ltd
11.6.1 CARSGEN Therapeutics?Ltd Company Information
11.6.2 CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.6.3 CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 CARSGEN Therapeutics?Ltd Main Business Overview
11.6.5 CARSGEN Therapeutics?Ltd Latest Developments
11.7 Juno Therapeutics
11.7.1 Juno Therapeutics Company Information
11.7.2 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.7.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Juno Therapeutics Main Business Overview
11.7.5 Juno Therapeutics Latest Developments
11.8 Kite Pharma
11.8.1 Kite Pharma Company Information
11.8.2 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.8.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Kite Pharma Main Business Overview
11.8.5 Kite Pharma Latest Developments
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Information
11.9.2 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.9.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Atara Biotherapeutics Main Business Overview
11.9.5 Atara Biotherapeutics Latest Developments
11.10 Carina Biotech
11.10.1 Carina Biotech Company Information
11.10.2 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.10.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Carina Biotech Main Business Overview
11.10.5 Carina Biotech Latest Developments
11.11 Guangzhou Xiangxue Pharmaceutical
11.11.1 Guangzhou Xiangxue Pharmaceutical Company Information
11.11.2 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.11.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Guangzhou Xiangxue Pharmaceutical Main Business Overview
11.11.5 Guangzhou Xiangxue Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2018-2029
2.1.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Segment by Type
2.2.1 Allogeneic CAR T-Cells
2.2.2 Autologous CAR T-Cells
2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
2.3.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
2.4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic Center
2.4.3 Others
2.5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
2.5.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
3 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Players
3.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Players (2018-2023)
3.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Players (2018-2023)
3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY BY REGIONS
4.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Regions (2018-2023)
4.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth (2018-2023)
4.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth (2018-2023)
4.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2018-2023)
5.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023)
5.3 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2018-2023)
6.2 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023)
6.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Country (2018-2023)
7.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023)
7.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Region (2018-2023)
8.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY MARKET FORECAST
10.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Regions (2024-2029)
10.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Regions (2024-2029)
10.1.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast
10.1.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast
10.1.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast
10.1.5 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast
10.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Country (2024-2029)
10.2.1 United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.2.2 Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.2.3 Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.2.4 Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Region (2024-2029)
10.3.1 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.2 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.3 Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.4 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.5 India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.6 Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Country (2024-2029)
10.4.1 Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4.2 France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4.3 UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4.4 Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4.5 Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Region (2024-2029)
10.5.1 Egypt Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5.2 South Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5.3 Israel Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5.4 Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5.5 GCC Countries Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.6 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Type (2024-2029)
10.7 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.1.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.2.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Information
11.3.2 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.3.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Bristol Myers Squibb Main Business Overview
11.3.5 Bristol Myers Squibb Latest Developments
11.4 Legend Biotech
11.4.1 Legend Biotech Company Information
11.4.2 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.4.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Legend Biotech Main Business Overview
11.4.5 Legend Biotech Latest Developments
11.5 Sorrento Therapeutics
11.5.1 Sorrento Therapeutics Company Information
11.5.2 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.5.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sorrento Therapeutics Main Business Overview
11.5.5 Sorrento Therapeutics Latest Developments
11.6 CARSGEN Therapeutics?Ltd
11.6.1 CARSGEN Therapeutics?Ltd Company Information
11.6.2 CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.6.3 CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 CARSGEN Therapeutics?Ltd Main Business Overview
11.6.5 CARSGEN Therapeutics?Ltd Latest Developments
11.7 Juno Therapeutics
11.7.1 Juno Therapeutics Company Information
11.7.2 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.7.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Juno Therapeutics Main Business Overview
11.7.5 Juno Therapeutics Latest Developments
11.8 Kite Pharma
11.8.1 Kite Pharma Company Information
11.8.2 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.8.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Kite Pharma Main Business Overview
11.8.5 Kite Pharma Latest Developments
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Information
11.9.2 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.9.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Atara Biotherapeutics Main Business Overview
11.9.5 Atara Biotherapeutics Latest Developments
11.10 Carina Biotech
11.10.1 Carina Biotech Company Information
11.10.2 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.10.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Carina Biotech Main Business Overview
11.10.5 Carina Biotech Latest Developments
11.11 Guangzhou Xiangxue Pharmaceutical
11.11.1 Guangzhou Xiangxue Pharmaceutical Company Information
11.11.2 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.11.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Guangzhou Xiangxue Pharmaceutical Main Business Overview
11.11.5 Guangzhou Xiangxue Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Allogeneic CAR T-Cells
Table 3. Major Players of Autologous CAR T-Cells
Table 4. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
Table 7. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
Table 10. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Player (2018-2023)
Table 12. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Key Players Head office and Products Offered
Table 13. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Regions (2018-2023)
Table 18. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Country (2018-2023)
Table 22. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
Table 24. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
Table 26. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Region (2018-2023)
Table 28. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
Table 30. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
Table 32. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Country (2018-2023)
Table 34. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
Table 36. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
Table 45. Key Market Challenges & Risks of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
Table 46. Key Industry Trends of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
Table 47. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Pfizer Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 52. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 53. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Novartis Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 57. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Bristol Myers Squibb Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 62. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 63. Bristol Myers Squibb Main Business
Table 64. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Bristol Myers Squibb Latest Developments
Table 66. Legend Biotech Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 67. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 68. Legend Biotech Main Business
Table 69. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Legend Biotech Latest Developments
Table 71. Sorrento Therapeutics Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 72. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 73. Sorrento Therapeutics Main Business
Table 74. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Sorrento Therapeutics Latest Developments
Table 76. CARSGEN Therapeutics?Ltd Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 77. CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 78. CARSGEN Therapeutics?Ltd Main Business
Table 79. CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. CARSGEN Therapeutics?Ltd Latest Developments
Table 81. Juno Therapeutics Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 82. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 83. Juno Therapeutics Main Business
Table 84. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Juno Therapeutics Latest Developments
Table 86. Kite Pharma Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 87. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 88. Kite Pharma Main Business
Table 89. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Kite Pharma Latest Developments
Table 91. Atara Biotherapeutics Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 92. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 93. Atara Biotherapeutics Main Business
Table 94. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Atara Biotherapeutics Latest Developments
Table 96. Carina Biotech Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 97. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 98. Carina Biotech Main Business
Table 99. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Carina Biotech Latest Developments
Table 101. Guangzhou Xiangxue Pharmaceutical Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 102. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 103. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Guangzhou Xiangxue Pharmaceutical Main Business
Table 105. Guangzhou Xiangxue Pharmaceutical Latest Developments
Table 1. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Allogeneic CAR T-Cells
Table 3. Major Players of Autologous CAR T-Cells
Table 4. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
Table 7. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
Table 10. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Player (2018-2023)
Table 12. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Key Players Head office and Products Offered
Table 13. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Regions (2018-2023)
Table 18. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Country (2018-2023)
Table 22. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
Table 24. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
Table 26. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Region (2018-2023)
Table 28. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
Table 30. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
Table 32. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Country (2018-2023)
Table 34. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
Table 36. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
Table 45. Key Market Challenges & Risks of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
Table 46. Key Industry Trends of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
Table 47. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Pfizer Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 52. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 53. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Novartis Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 57. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Bristol Myers Squibb Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 62. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 63. Bristol Myers Squibb Main Business
Table 64. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Bristol Myers Squibb Latest Developments
Table 66. Legend Biotech Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 67. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 68. Legend Biotech Main Business
Table 69. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Legend Biotech Latest Developments
Table 71. Sorrento Therapeutics Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 72. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 73. Sorrento Therapeutics Main Business
Table 74. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Sorrento Therapeutics Latest Developments
Table 76. CARSGEN Therapeutics?Ltd Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 77. CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 78. CARSGEN Therapeutics?Ltd Main Business
Table 79. CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. CARSGEN Therapeutics?Ltd Latest Developments
Table 81. Juno Therapeutics Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 82. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 83. Juno Therapeutics Main Business
Table 84. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Juno Therapeutics Latest Developments
Table 86. Kite Pharma Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 87. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 88. Kite Pharma Main Business
Table 89. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Kite Pharma Latest Developments
Table 91. Atara Biotherapeutics Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 92. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 93. Atara Biotherapeutics Main Business
Table 94. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Atara Biotherapeutics Latest Developments
Table 96. Carina Biotech Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 97. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 98. Carina Biotech Main Business
Table 99. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Carina Biotech Latest Developments
Table 101. Guangzhou Xiangxue Pharmaceutical Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 102. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 103. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Guangzhou Xiangxue Pharmaceutical Main Business
Table 105. Guangzhou Xiangxue Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Country/Region (2022)
Figure 8. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type in 2022
Figure 10. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in Hospital
Figure 11. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in Diagnostic Center
Figure 13. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Diagnostic Center (2018-2023) & ($ Millions)
Figure 14. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in Others
Figure 15. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application in 2022
Figure 17. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Player in 2022
Figure 18. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Value Market Share by Country in 2022
Figure 24. United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Region in 2022
Figure 29. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type in 2022
Figure 30. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application in 2022
Figure 31. China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Country in 2022
Figure 38. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 61. China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 65. India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 68. France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Country/Region (2022)
Figure 8. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type in 2022
Figure 10. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in Hospital
Figure 11. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in Diagnostic Center
Figure 13. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Diagnostic Center (2018-2023) & ($ Millions)
Figure 14. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in Others
Figure 15. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application in 2022
Figure 17. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Player in 2022
Figure 18. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Value Market Share by Country in 2022
Figure 24. United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Region in 2022
Figure 29. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type in 2022
Figure 30. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application in 2022
Figure 31. China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Country in 2022
Figure 38. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 61. China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 65. India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 68. France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share Forecast by Application (2024-2029)
